SEC Filing Summary for ADMA Biologics, Inc.

This filing details transactions by Jerrold B. Grossman, a director at ADMA Biologics, Inc. On May 11, 2026, Grossman acquired 12,500 shares of common stock through an open market purchase at $8.01 per share, increasing his direct holdings to 501,384 shares. The filing also discloses indirect holdings through various entities and his wife, including shares held by Brookwood LLC, the Jerrold Grossman 2019 Irrevocable Trust, Genesis Foundation Inc., and his wife. These indirect holdings, as detailed in the footnotes, represent a significant portion of his overall beneficial ownership. The transactions were reported on Form 4.